Francis H. Murphy

85 year

Consumer Services

Health Technology

Finance

Profile

Francis H.
Murphy worked as the Chief Financial & Accounting Officer at Biopure Corp.
from 1999 to 2007.
He was also a Member at Beacon Angels Services, LLC.
Murphy holds an MBA from Boston University and an undergraduate degree from Rutgers State University of New Jersey.

Former positions of Francis H. Murphy

Companies	Position	End
Biopure Corp. Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA.	Director of Finance/CFO	2007-10-09
Beacon Angels Services, LLC Beacon Angels Services, LLC Investment ManagersFinance Beacon Angels Services LLC (Beacon Angels) is a ventures capital firm founded in 2006 by Daniel S. Von Kohorn and William F. Swiggart. The firm is headquartered in Boston, Massachusetts.	Private Equity Investor	2011-03-31

See the detail of Francis H. Murphy's experience

Training of Francis H. Murphy

Boston University	Masters Business Admin
Rutgers State University of New Jersey	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Francis H. Murphy's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Biopure Corp. Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA.	Health Technology
Beacon Angels Services, LLC Beacon Angels Services, LLC Investment ManagersFinance Beacon Angels Services LLC (Beacon Angels) is a ventures capital firm founded in 2006 by Daniel S. Von Kohorn and William F. Swiggart. The firm is headquartered in Boston, Massachusetts.	Finance